Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jul;81(1):e13-e20.
doi: 10.1016/j.jinf.2020.03.062. Epub 2020 Apr 10.

The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

Affiliations
Meta-Analysis

The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

Zhenwei Yang et al. J Infect. 2020 Jul.

Abstract

Objectives: An outbreak of novel coronavirus in 2019 threatens the health of people, and there is no proven pharmacological treatment. Although corticosteroids were widely used during outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, their efficacy remainedhighly controversial. We aimed to further evaluate the influence of corticosteroids on patients with coronavirus infection.

Methods: We conducted a comprehensive search of literature published in PubMed, Embase, Cochrane library, and China National Knowledge Infrastructure (CNKI) from January 1, 2002 to March 15, 2020. All statistical analyses in this study were performed on stata14.0.

Results: A total of 5270 patients from 15 studies were included in this meta-analysis. The result indicated that critical patients were more likely to require corticosteroids therapy (risk ratio [RR] = 1.56, 95% confidence interval [CI] = 1.28-1.90, P<0.001). However, corticosteroid treatment was associated with higher mortality (RR = 2.11, 95%CI = 1.13-3.94, P = 0.019), longer length of stay (weighted mean difference [WMD] = 6.31, 95%CI = 5.26-7.37, P<0.001), a higher rate of bacterial infection (RR = 2.08, 95%CI = 1.54-2.81, P<0.001), and hypokalemia (RR = 2.21, 95%CI = 1.07-4.55, P = 0.032) but not hyperglycemia (RR = 1.37, 95%CI=0.68-2.76, P = 0.376) or hypocalcemia (RR = 1.35, 95%CI = 0.77-2.37, P = 0.302).

Conclusions: Patients with severe conditions are more likely to require corticosteroids. Corticosteroid use is associated with increased mortality in patients with coronavirus pneumonia.

Keywords: COVID-19; Coronavirus; Meta-analysis; corticosteroid treatment.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest No authors have competing interests in this research.

Figures

Fig 1
Fig. 1
Flow chart of literature search and selection of studies.
Fig 2
Fig. 2
The use of corticosteroids in critical and non-critical patients.
Fig 3
Fig. 3
Effect of corticosteroids on mortality.
Fig 4
Fig. 4
Effect of corticosteroids on length of stay (LOS).
Fig 5
Fig. 5
(A) Funnel plot of the use of corticosteroids in critical and non-critical patients. (B) Funnel plot of mortality.

Comment in

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–733. PubMed PMID: 31978945. Epub 2020/01/25. eng. - PMC - PubMed
    1. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. 2020:2020.02.07.937862.
    1. WHO. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February2020. Available from:https://www.who.int/zh/dg/speeches/detail/who-director-general-s-remarks....
    1. He F., Deng Y., Li W.Coronavirus disease 2019 (COVID-19): what we know?J Med Virol. 2020 Mar 14. PubMed PMID: 32170865. Epub 2020/03/15. eng. - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020 Feb 15;395(10223):497–506. PubMed PMID: 31986264. Epub 2020/01/28. eng. - PMC - PubMed

Publication types

Substances